The Palico Private Equity Fund Marketplace
TPG Biotech is a private equity general partner firm headquartered in San Francisco, CA, United States.
Israel-based Nutrinia, an insulin developer for infants, has raised $30m in Series D funding led by TPG Biotech.
TPG Capital is to acquire Beaver-Visitec International, a global developer, manufacturer, and marketer of specialized surgical devices.
Alphabet Energy, a CA-based developer of thermoelectrics for waste heat to power, closed a $23.5m Series C round of financing.
Read more news concerning TPG Biotech
A sampling of TPG Biotech portfolio companies:
View all of the investments in their portfolio
This firm also pursues other investment strategies:
Registration is fast, free and easy
Already a member?